000			03329nam a22004815i 4500
001			978-3-7643-7563-8
003			DE-He213
005			20161121230811.0
007			cr nn 008mamaa
008			100301s2007 sz | s |||| 0|eng d
020			_a9783764375638 _9978-3-7643-7563-8
024	7		_a10.1007/978-3-7643-7563-8 _2doi
050		4	_aQR46
072		7	_aMMFM _2bicssc
072		7	_aMED052000 _2bisacsh
082	0	4	_a616.9041 _223
100	1		_aSuttorp, Norbert. _eauthor.
245	1	0	_aCommunity-Acquired Pneumonia _h[electronic resource] / _cby Norbert Suttorp, Tobias Welte, Reinhard Marre.
264		1	_aBasel : _bBirkhäuser Basel, _c2007.
300			_aIX, 250 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aBirkhäuser Advances in Infectious Diseases
505	0		_aDiagnosis and treatment of community acquired pneumonia - the German perspective -- Detection of respiratory bacterial pathogens -- Viral pathogens and epidemiology, detection, therapy and resistance -- Resistance in Streptococcus pneumoniae -- Influenza -- Pathogenesis of Chlamydophila pneumoniae infections — epidemiology, immunity, cell biology, virulence factors -- Legionnaires’ disease and its agent Legionella pneumophila -- Pathogenesis of Streptococcus pneumoniae infections:adaptive immunity, innate immunity, cell biology, virulence factors -- Pathogenesis of Mycoplasma pneumoniae infections:adaptive immunity, innate immunity, cell biology, and virulence factors -- Community-acquired pneumonia: paving the way towards new vaccination concepts.
520			_aCommunity-acquired pneumonia (CAP) is a disease associated with high morbidity and mortality, with at least one third of cases requiring hospitalization, exceeding the numbers admitted for myocardial infarction and stroke. Despite a broad armamentarium of antimicrobials available, it remains an important cause of death in industrialized countries. CAP is caused by a variety of pathogens with their order of importance dependent on the location and population studied. Despite the importance of CAP, reliable data and a recommended evidence-based therapy are lacking, and basic research must be improved. The goal of this volume is to present state-of-the-art knowledge on epidemiology, clinical presentation, immunology, pathology, and diagnosis including the identification of "new pathogens". Therapeutic approaches, antibiotics resistance, disease management and vaccination strategies are also covered. The volume is of interest to researchers and clinicians in virology, epidemiology and biomedicine.
650		0	_aMedicine.
650		0	_aMedical microbiology.
650		0	_aMolecular biology.
650	1	4	_aBiomedicine.
650	2	4	_aMedical Microbiology.
650	2	4	_aMolecular Medicine.
700	1		_aWelte, Tobias. _eauthor.
700	1		_aMarre, Reinhard. _eauthor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783764375621
830		0	_aBirkhäuser Advances in Infectious Diseases
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-7643-7563-8
912			_aZDB-2-SBL
950			_aBiomedical and Life Sciences (Springer-11642)
999			_c504154 _d504154